Indoco Remedies says Maharashtra GST inspection completed, operations unaffected

Shares of Indoco Remedies Ltd ended at ₹205.10, down by ₹8.65, or 4.05%, on the BSE.

Shares of Indoco Remedies Ltd ended at ₹205.10, down by ₹8.65, or 4.05%, on the BSE.

GSFC reported a steady Q3 performance with profit up 18% year-on-year and margin expansion, supported by modest revenue growth. Shares ended over 2% higher post results.

While Jefferies, Nuvama and UBS have ‘buy’ ratings on the Navine Fluorine stock, Citi has a ‘sell’ recommendation. All analysts have raised their target prices.

An aggressive expansion in North India may take the stock down below its current 52-week low, says one analyst.

Management said demand improvement seen after GST 2.0 has continued. Bata also reported robust growth in key brands such as Hush Puppies and Power, and added 27 franchise stores during the quarter.

Bangladesh secures US zero-duty access for garments using US cotton, raising concerns for Indian cotton exporters. Experts see limited impact, with integrated Indian firms better positioned.

Lupin Limited settles patent dispute with Astellas Pharma over Mirabegron, paying $90 million and ongoing fees, securing US sales and improving revenue visibility through mid-FY28.

The price of lumps is now ₹4,700 per tonne and of fines is ₹4,000 per tonne. The same is in effect from Tuesday, February 10.

Meta and Google face landmark trials over claims their platforms addict and harm children, with KGM’s case in Los Angeles potentially shaping thousands of similar lawsuits worldwide.

CLSA says Axis would likely make an open offer and acquire the entire entity. At current market prices, the total consideration is estimated at around $2.3 billion, which it believes is manageable for a bank of Axis Bank’s size.